Metabolomics Market Size, Share, Growth & Forecast | 2031

Metabolomics Market Size, Share, Growth & Forecast | 2031

Segments - Metabolomics Market by Applications (Toxicology, Biomarker & Drug Discovery, Personalized Medicine, Nutrigenomics, and Others), Production Technology (Liquid Chromatography, Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, Capillary Electrophoresis, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2576 | 4.4 Rating | 63 Reviews | 210 Pages | Format : PDF Excel PPT

Report Description


Metabolomics Market Outlook 2031

The global metabolomics market size was USD 2.56 Billion in 2022 and is estimated to reach  USD 7.21 Billion by 2031, expanding at a CAGR of 12.2% during the forecast period, 2023–2031. The growth of the market is attributed to the increasing R&D expenditure in the biopharmaceuticals & pharmaceutical industry, rising investment of government and private institution on metabolomics research, and ongoing improvements in metabolomics instruments.

Scientifically, metabolomics is the study of specific chemical processes within cells that include metabolites. Furthermore, metabolites refers to all of the metabolites found in a biological cell, organ, and tissue collectively, which are the end products of cellular processes.

Metabolomics Market Outook

Moreover, metabolomics is a relatively new field that encompasses the measurement of all metabolites and low-molecular-weight compounds in a biological material. Furthermore, it provides for the profiling of a far higher number of metabolites than traditional clinical laboratory techniques.

As a result of its comprehensive coverage of biological processes and metabolic pathways, it continues to be a fundamental objective lens for precision medicine in molecular microscopes.

However, metabolites are closely related to an organism's phenotype and can be utilized for a variety of purposes including phenotyping genetically altered plants, identifying gene function, studying biotic-abiotic stress reactions, and significant equivalence testing. Furthermore, it aids researchers and scientists in calculating physiological effects and observing the negative effects of medications on an organism.


The COVID-19 pandemic has severely impacted on the life science instruments market. The manufacturing and supply chain related challenges affected the analytical instruments industry such as getting products to end users on time and meeting inconsistent demand for products and services for few months.

  • Increasing geriatric population globally as well as rising cases of diabetes and cancer are some of the key factors propelling the market growth.
  • Growing adoption rate of metabolomics as a R&D tool and increasing usage of metabolomics as drug discovery tool by key pharmaceutical companies are fueling the market expansion.
  • Increasing patient awareness levels and cost effective toxicological studies on investigational drugs are some other key drivers of the market.
  • High data complexity generated during life science research and difficulty in effective data points evaluation are key restraining factors that can hinder the growth of the metabolomics market.
  • Technological advancement in metabolomics to identify new biomarkers related to sensitivity, safety, and resistance to commercially available drugs is expected to offer tremendous opportunity for market growth in the coming years.

Scope of Metabolomics Market Report

The report on the global metabolomics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Metabolomics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Applications (Toxicology, Biomarker & Drug Discovery, Personalized Medicine, Nutrigenomics, and Others) and Production Technology (Liquid Chromatography, Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, Capillary Electrophoresis, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Human Metabolome Technologies; Phenomenome Discoveries Inc.; Bruker Corp.; Metabolon, Inc.; and Agilent Technologies.

Metabolomics Market Segment Insights

Applications Segment Analysis

Based on applications, the global metabolomics market is segmented into toxicology, biomarker & drug discovery, personalized medicine, nutrigenomics, and others. The biomarker & drug discovery segment is expected to grow at a rapid pace during the forecast period, due to the growing challenges faced by the pharmaceutical industry such as declining discovery pipelines, less budget endorsed for a particular R&D, rising regulatory control, and significant gaps in the future drug markets.

Moreover, the objective and quantitatively observable signs of biological or pathological processes are known as biomarkers. Both metabolomics and biomarkers are increasingly being employed in medication research and disorder management, particularly for personalized medicine.

In addition, metabolomics and biomarkers are likely to promote drug discovery and tailored therapy, particularly in high-demand disease areas, such as cancer, cardiovascular & metabolic diseases, mental health, and other infectious diseases. Thus, all these factors are expected to boost the segment growth.

Metabolomics Market Application

Production Technology Segment  Analysis

On the basis of production technology, the market is segregated as liquid chromatography, mass spectrometry, nuclear magnetic resonance spectroscopy, gas chromatography, capillary electrophoresis, and others.

The gas chromatography (GC) segment is projected to expand at a considerable CAGR during the forecast period owing to the advanced technology in analytical instruments such as miniaturization, automation, and computerization, growing number of R&D activities in the field of medicine, nutraceuticals, and metabolomics, and well established healthcare infrastructure in emerging economies for efficient disease diagnosis and treatment.


Moreover, the National Institute of Health Sciences (NIHS) in Japan has approved the use of gas chromatography and liquid chromatography and gas chromatography for drug testing, particularly in determining the purity and efficacy of new pharmacological analyses.

Furthermore, high usage of gas chromatography in medication approvals and growing government support in the form of subsidies are estimated to boost the segment growth.

Regional Outlook

In terms of regions, the global metabolomics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period.

The regional market growth is attributed to the presence of key pharmaceutical companies operating in the metabolomics market and increasing biomedical research especially in the US and ongoing preclinical activities by contract research organizations (CROs) in the region.


However, the Asia Pacific market is projected to register a substantial CAGR during the forecast period. The growth of the market in the region is attributed to the increasing demand for enhanced pharmaceutical products from developing economies such as India and China, and the encouraging government policies to support new product development by key players.

Metabolomics Market Region

Segments

The global metabolomics market has been segmented on the basis of

Applications

  • Toxicology
  • Biomarker & Drug Discovery
  • Personalized Medicine
  • Nutrigenomics
  • Others

Production Technology

  • Liquid Chromatography
  • Mass Spectrometry
  • Nuclear Magnetic Resonance Spectroscopy
  • Gas Chromatography
  • Capillary Electrophoresis
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Some of the key players competing in the global metabolomics market are Human Metabolome Technologies; Phenomenome Discoveries Inc.; Bruker Corp.; Metabolon, Inc.; and Agilent Technologies. These major players are implementing various marketing strategies such as capital investments, merger & acquisitions, and new product development to enhance their market position in the regional as well as global competition.

Moreover, high performance liquid chromatography (HPLC) and ultra performance liquid chromatography (UPLC) are increasingly preferred over other techniques for their most adaptable separation method in metabolite research due to the unique requirements.

To characterize toxicological investigations and develop novel medications against infectious diseases, several pharmaceutical firms prefer research centers. Furthermore, technical developments as well as their integration with multiple sclerosis and nuclear magnetic resonance (NMR) are increasingly gaining traction around the world.

Metabolomics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Metabolomics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Metabolomics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Metabolomics Market - Supply Chain
  4.5. Global Metabolomics Market Forecast
     4.5.1. Metabolomics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Metabolomics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Metabolomics Market Absolute $ Opportunity
5. Global Metabolomics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Metabolomics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Metabolomics Demand Share Forecast, 2019-2026
6. North America Metabolomics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Metabolomics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Metabolomics Demand Share Forecast, 2019-2026
7. Latin America Metabolomics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Metabolomics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Metabolomics Demand Share Forecast, 2019-2026
8. Europe Metabolomics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Metabolomics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Metabolomics Demand Share Forecast, 2019-2026
9. Asia Pacific Metabolomics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Metabolomics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Metabolomics Demand Share Forecast, 2019-2026
10. Middle East & Africa Metabolomics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Metabolomics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Metabolomics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Metabolomics Market: Market Share Analysis
  11.2. Metabolomics Distributors and Customers
  11.3. Metabolomics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Methodology

Our Clients

Nestle SA
General Mills
Deloitte
sinopec
Dassault Aviation
Siemens Healthcare
The John Holland Group
FedEx Logistics